Latest filing published 29 Nov 2023 for PaxMedica, Inc., €174.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Michael Derby appears in our data through filings on PaxMedica, Inc. shares, published by SEC (Form 4). Between 30 August 2022 and 27 November 2023, the trades on record add up to 13 filings.
On the open market, the record shows 1 purchase worth €498k and 9 sales worth €108k. Netting one side against the other leaves €389k of net buying. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 3 share grants. 2023 to date brings no purchases and 9 sales.
On 29 November 2023 came the latest disclosure, an open-market sale for €174 in PaxMedica, Inc. The clock since the last published purchase (1 September 2022) now reads 1,514 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations